Program Information

	Treatment Response	Tuesday - 7/14/2015
	Joint Imaging - Therapy Scientific Session	4:30 PM - 6:00 PM	Room: Ballroom A

Moderator 1: John Bayouth, University of Wisconsin
Moderator 2: Stewart Gaede, London Regional Cancer Program

Tuesday 4:30 PM TU-G-BRA-1

Assessing Radiation-Induced Reductions in Regional Lung Perfusion Following Stereotactic Radiotherapy for Lung Cancer R. McGurk*, E. Schreiber, S. Das, T. Zagar, R. Green, M. Lawrence, A. Sheikh, W. McCartney, P. Rivera, L. Marks

Tuesday 4:40 PM TU-G-BRA-2

Can We Extract Lung Function Directly From 4D-CT Without Deformable Image Registration? J. Kipritidis*, M. Hofman, S. Siva, J. Callahan, P. Le Roux, H. Woodruff, W. Counter, N. Hardcastle, P. Keall

Tuesday 4:50 PM TU-G-BRA-3

Predicting Radiation Therapy Induced Ventilation Changes Using 4DCT Jacobian Calculations T. Patton*, K. Du, G. Christensen, J. Reinhardt, J. Bayouth

Tuesday 5:00 PM TU-G-BRA-4

Changes in Regional Lung Function Measured by 4D-CT Ventilation Imaging for Thoracic Radiotherapy Y. Nakajima*, N. Kadoya, S. Kabus, B. Loo, P. Keall, T. Yamamoto

Tuesday 5:10 PM TU-G-BRA-5

Predicting Volume Change of the Tumor and Critical Structures Throughout Radiation Therapy by CT-CBCT Registration with Local Intensity Correction S. Park*, A. Robinson, W. Plishker, R. Shekhar, A. Kiess, H. Quon, J. Wong, J. Lee

Tuesday 5:20 PM TU-G-BRA-6

PET-Based Treatment Response Assessement for Neoadjuvent Chemoradiation for Pancreatic Adenocarcinoma E. Dalah*, A. Tai, K. Oshima, W. Hall, B. Erickson, X. Li

Tuesday 5:30 PM TU-G-BRA-7

Characterization of Tumor Proliferation During Successive Cycles of Anti-Angiogenic Therapy Using [F-18]FLT PET/CT M. Scarpelli*, S. Perlman, S. Harmon, T. Perk, P. Scully, J. Bruce, G. Liu, R. Jeraj

Tuesday 5:40 PM TU-G-BRA-8

BEST IN PHYSICS (JOINT IMAGING-THERAPY): Hybrid PET-MRI Imaging of Acute Radiation Induced Cardiac Toxicity O. El-Sherif*, I. Xhaferllari, J. Sykes, J. Butler, G. Wisenberg, F. Prato, S. Gaede

Tuesday 5:50 PM TU-G-BRA-9

MR Elastography as a Predictor of Therapeutic Response: Assessment in Non-Hodgkin's Lymphoma (NHL) K. Pepin*, S. Ansell, R. Ehman, K. McGee